







Idiopathic intracranial hypertension (IIH) is a well recognized condition of elevated intracranial pressure of unknown cause. 
Many etiologies have been proposed, but few- besides a high body mass index, hypervitaminosis A, steroid withdrawal,
exposure to tetracyclines and female gender- have been proven. The main morbidity in this condition is visual loss and is
often reversed if recognized early and treated promptly with weight- reduction, a low-sodium diet and acetazolamide.
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Introduction
Idiopathic intracranial hypertension 
(IIH), also known as pseudotumor cere-
bri, is a clinical condition of elevated 
intracranial pressure of unknown etio-
logy. Typical presentation consists of 
daily headache, pulse-synchronous 
tinnitus, transient blurred vision, papi-
lledema with associated visual loss, 
and diplopia from abducens nerve 
paresis. (1) 
Several conditions have been suspec-
ted, but only a few, including obesity 
and weight gain during the 12 months 
before diagnosis, steroid withdrawal, 
female gender, hypervitaminosis A and 
related compounds, have been pro-
ven. (2-4)
The treatment is focused on the correc-
tion of the presumed cause, including 
a low-sodium diet, diuretics and a wei-
ght-reduction program. (5)
To our knowledge, we describe, possi-
bly, the first adult patient with complete 
oculomotor palsy.
Case report
A 53-year old, right-handed woman 
presented with an acute onset of sharp 
pain involving the top of her head asso-
ciated with nausea, vomiting, photo 
and pnonophobia two weeks prior to 
her neurological visit. At that time she 
was hospitalized and treated symp-
tomatically for headache. During the 
patient’s hospitalization, left ptosis was 
noticed by her primary doctor. 
Initial metabolic work-up was unremar-
kable and an MRI (magnetic resonance 
imaging) was performed, remarkable 
for a partially empty sella, not reported 
by the radiologist (figure 1). No other 
abnormalities were seen. Cavernous 
sinus was normal and no abnormal 
enhancement with gadolinium was 
seen.
The patient had been headache free for 
an entire week prior to her neurological 
exam, and the only complaint she had 
was not being able to elevate her left 
eyelid. She denied any fever, visual 
obscuration, diplopia or tinnitus.
Past medical history was remarkable for 
migrainous headaches, (she had been 
headache free for years prior to this 
event), hypertension and depression.
While being on the antidepressant, ven-
lafaxine, she has gained 45 pounds 
during the previous 12 months.
Physical exam revealed 5’8’’ height, 
228 pounds weight, blood pressure of 
150/90 mm Hg and regular heart rate 
of 70.
Fundoscopic examination revealed 
grade III papilledema OS (left eye), 
grade II OD (right eye). There was no 
ocular or carotid bruit. The cardiac exa-
mination was normal, without murmur.
Neurological examination was remar-
kable for complete left ptosis, mydria-
sis, light stimulation revealed OS 5mm 
down to 4mm, OD 3mm down to 2mm, 
normal abduction and complete palsy 
of occulomotor innervated muscles on 
the left.
Right extraocular motor activity was 
entirely normal. No visual field defect 
was detected.
An emergent magnetic resonance angi-
ogram (MRA) and venogram (MRV) 
were obtained without any abnormali-
ties. In particular, there was no eviden-
ce of intracranial aneurysm or venous 
sinus thrombosis.
Subsequently, the same day a spinal 
tap was performed and revealed ele-
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vated intracranial pressure of 420 mm 
water. Closing pressure was 100 mm 
water after 30 ml of clear cerebrospi-
nal fluid (CSF) was removed.  Anal-
ysis of CSF was normal, cytology was 
also normal, no malignant cells were 
found. The repeated metabolic work-
up, including sederate, C - reactive 
protein and antinuclear antibodies was 
normal.
The patient was immediately started on 
acetalozamide 500 mg twice daily, a 
weight reduction program and instruc-
ted to contact her psychiatrist regar-
ding stopping venflaxine and starting 
another antidepressant. The patient’s 
symptoms resolved two weeks later, 
with no residual left oculomotor deficit 
and normal pupillary response.
Discussion.
The annual incidence of IIH is 0.9/100 
000 persons and 3.5/100 000 in fema-
les 15 to 44 years old. Among obese 
women the incidence is 19/100 000. (6) 
More than 90% of IIH patients are obese 
and more than 90% are women of chil-
dbearing age. Female preponderance 
and the association of obesity is true 
only for postpubertal patients. (7)
The mean age at diagnosis is 30 years. 
(6) There have been no reports of ven-
flaxine induced IIH, but it can produce 
weight gain. (8) 
The most accepted hypothesis is that 
IIH is a syndrome of reduced CSF 
absorption and current analysis has 
concluded that histological features of 
the brain are normal. (9)
The presenting symptoms are heada-
ches in 94% of patients, transient visual 
obscuration in 68%, pulse synchronous 
tinnitus in 58%, photopsia in 54% and 
retrobulbar pain in 44%. (10-14) Diplo-
pia, which occurs in 38% of patients 
due to abducens nerve paresis, (15) 
and loss of vision, occurring in 30% of 
patients, (16) are less common.
The major signs of IIH are papilledema 
and paresis of the abducens nerve. 
(16,17)
This case report raises several impor-
tant issues. First, even a relatively late 
onset of headaches (after age 50) and 
signs of oculomotor nerve paresis must 
raise the suspicion of IIH  if other etio-
logies have been previously excluded, 
such as an intracranial aneurysm or 
any other compressive lesion. Second, 
despite the “empty sella” abnormality 
on MRI, very often underreported by 
an interpreting radiologist, and if repor-
ted usually interpreted of no clinical 
Figure 1. Sagital MRI of the brain with gadolinium shows a partially empty 
sella.
We are aware of just a few clinical 
reports of IIH and oculomotor nerve 
involvement in the pediatric popula-
tion, (18,19) and two  additional pati-
ents have been reported, but age was 
unknown at the onset (20,21) with spa-
ring of pupillary fibers in all described 
cases. There has been no single report 
of complete oculomotor palsy to our 
knowledge.
significance, it might be, in a particu-
lar setting, very important information. 
(22,23) Third, even though there have 
been no previous reports of venflaxine 
induced IIH,  we still believe the under-
lying mechanism is weight gain; this 
possibility cannot be completely exc-
luded. Fourth, prompt diagnosis of IIH 
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